Tobramycin Injection
Product Images NDC 36000-244

4 FDA label images from Baxter Healthcare Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 36000-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-description (Image Description)

Image-description (Image Description)
Chemical structure of Tobramycin, an aminoglycoside antibiotic. The structure depicts three linked sugar rings with multiple amino and hydroxyl groups, characteristic of Tobramycin's molecular framework.*
FDA Label Image

Tobramycin-nomogram (Tobramycin Nomogram)

Tobramycin-nomogram (Tobramycin Nomogram)
A line graph depicting a reduced dosage nomogram for Tobramycin injection, showing percent of normal dosage from Table 3 versus serum creatinine and creatinine clearance. The graph demonstrates an inverse relationship between serum creatinine levels and dosage adjustment for Tobramycin.*
FDA Label Image

Tobramycin-container-label-2ml (Tobramycin Container Label 2ml)

Tobramycin-container-label-2ml (Tobramycin Container Label 2ml)
Label for Tobramycin Injection, USP 80 mg/2 mL (40 mg/mL) in a 2 mL multiple dose vial. The label instructs use for intravenous (IV) or intramuscular (IM) administration with required dilution for IV use. Manufactured for Baxter Healthcare Corporation, Deerfield, IL. The label includes storage instructions and a barcode.*
FDA Label Image

Tobramycin-container-label-30ml (Tobramycin Container Label 30ml)

Tobramycin-container-label-30ml (Tobramycin Container Label 30ml)
Label for Tobramycin Injection, USP 1200 mg/30 mL (40 mg/mL) multiple dose vial by Baxter Healthcare Corporation. Intended for intravenous or intramuscular use, the label includes storage instructions, ingredient content, and a barcode. Manufactured by Baxter Healthcare Corporation, Deerfield, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.